Identification of Trypanosoma cruzi Trans-Sialidase Family Members as Targets of Protective CD8+ TC1 Responses

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6120-6130

  Wizel, Benjamin ^a   Nunes, Marise ^a   Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN; H 2KB PROTEIN, MOUSE; H-2KB PROTEIN, MOUSE; H2 ANTIGEN; PARASITE ANTIGEN; SIALIDASE; TRANS SIALIDASE; TRANS-SIALIDASE;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; C3H MOUSE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL LINE; CHAGAS DISEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR WEIGHT; MORTALITY; MOUSE; PARASITOLOGY; PROTEIN BINDING; SECRETION; SPECIES DIFFERENCE; TRYPANOSOMA CRUZI;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CHAGAS DISEASE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GLYCOPROTEINS; H-2 ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR WEIGHT; NEURAMINIDASE; PROTEIN BINDING; SPECIES SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TRYPANOSOMA CRUZI; TUMOR CELLS, CULTURED;

EID: 0031573518     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. World Health Organization. 1995. Twelfth Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. In WHO-Tropical Disease Research, World Health Organization, Geneva, p. 125.
2. Santos-Buch, C. A., and A. M. Acosta. 1985. Pathology of Chagas' disease. In Immunology and Pathology of Trypanosomiasis. I. Tizard, ed. CRC Press, Boca Raton, p. 145.
3. Tarleton, R. 1996. Immunity to Trypanosoma cruzi. In Host Response to Intracellular Pathogens. S. Kaufmann, ed. R. G. Landes Company, Austin, p. 227.
4. Kuhn, R. 1994. Macrophages in experimental Chagas' disease. Immunol. Ser. 60:495.
5. Roberson, E., and W. Hanson. 1973. Trypanosoma cruzi: effects of antithymocyte serum in mice and neonatal thymectomy in rats. Exp. Parasitol. 34:168.
6. Kierszenbaum, F., and M. Pienkowski. 1979. Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection. Infect. Immun. 24: 117.
7. Trischmann, T., and B. Bloom. 1980. Trypanosoma cruzi: ability of T-cell-enriched and -depleted lymphocyte populations to passively protect mice. Exp. Parasitol. 49:225.
8. Reed, S. 1980. Adoptive transfer of resistance to acute Trypanosoma cruzi infection with T-lymphocyte-enriched spleen cells. Infect. Immun. 28:404.
9. Nickell, S., A. Gebremichael, R. Hoff, and M. Boyer. 1987. Isolation and functional characterization of murine T cell lines and clones specific for the protozoan parasite Trypanosoma cruzi. J. Immunol. 138:914.
10. Rottenberg, M., R. Cardoni, R. Andersson, E. Segura, and A. Orn. 1988. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand. J. Immunol. 28:573.
11. +) T lymphocytes. Infect. Immun. 57:2246.
12. + T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens. Infect. Immun. 61:3250.
13. Rottenberg, M., M. Bakhiet, T. Olsson, K. Kristensson, T. Mak, H. Wigzell, and A. Orn. 1993. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 61:5129.
14. Tarleton, R., J. Sun, L. Zhang, and M. Postan. 1994. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect. Immun. 62:1820.
15. Tarleton, R., M. Grusby, M. Postan, and L. Glimcher. 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8:13.
16. Burleigh, B., and N. Andrews. 1995. The mechanisms of Trypanosoma cruzi invasion of mammalian cells. Annu. Rev. Microbiol. 49:175.
17. Andrews, N., E. Robbins, V. Ley, K. Hong, and V. Nussenzweig. 1988. Developmentally regulated, phospholipase C-mediated release of the major surface glycoprotein of amastigotes of Trypanosoma cruzi. J. Exp. Med. 167:300.
18. Andrews, N., C. Abrams, S. Slatin, and G. Griffiths. 1990. A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. Cell 61:1277.
19. Frevert, U., S. Schenkman, and V. Nussenzweig. 1992. Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi. Infect. Immun. 60:2349.
20. Hall, B., P. Webster, A. Ma, K. Joiner, and N. Andrews. 1992. Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. J. Exp. Med. 176:313.
21. Garg, N., M. P. Nunes, and R. L. Tarleton. 1997. Delivery by Trypanosoma cruzi of proteins into MHC class I antigen processing and presentation pathway. J. Immunol. 158:3293.
22. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
23. + T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144:717.
24. 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356:338.
25. Rottenberg, M., A. Riarte, L. Sporrong, J. Altcheh, P. Petray, A. Ruiz, H. Wigzell, and A. Orn. 1995. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunol. Lett. 45:53.
26. +, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. J. Immunol. 150:1446.
27. + cells and natural cytotoxic activity among spleen, blood, and heart lymphocytes during the acute phase of Trypanosoma cruzi infection in rats. Infect. Immun. 60:1024.
28. + T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 48:161.
29. Higuchi, M. d. L., P. Gutierrez, V. Aiello, S. Palomino, E. Bocchi, J. Kalil, G. Bellotti, and F. Pileggi. 1993. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch. A. Pathol. Anal. Histopathol. 423:157.
30. + lymphocytes. Am. J. Trop. Med. Hyg. 48:637.
31. Engelhard, V. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:13.
32. Pamer, E., J. Harty, and M. Bevan. 1991. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852.
33. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. Robbins, L. Rivoltini, J. Yannelli, E. Appella, and S. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347.
34. Brander, C., W. Pichler, and G. Corradin. 1995. Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine. Clin. Exp. Immunol. 101:107.
35. Wizel, B., R. Houghten, K. Parker, J. Coligan, P. Church, D. Gordon, W. Ballou, and S. Hoffman. 1995. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. J. Exp. Med. 182:1435.
36. Hosmalin, A., M. Clerici, R. Houghten, C. Pendleton, C. Flexner, D. Lucey, B. Moss, R. Germain, G. Shearer, and J. Berzofsky. 1990. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 87:2344.
37. Wizel, B., W. Rogers, R. Houghten, D. Lanar, J. Tine, and S. Hoffman. 1994. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. Eur. J. Immunol. 24:1487.
38. Wizel, B., R. Houghten, P. Church, J. Tine, D. Lanar, D. Gordon, W. Ballou, A. Sette, and S. Hoffman. 1995. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155:766.
39. Kuhn, R., and J. Murnane. 1977. Trypanosoma cruzi: immune destruction of parasitized mouse fibroblasts in vitro. Exp. Parasitol. 41:66.
40. Hanson, W., W. Chapman, and V. Waits. 1976. Immunization of mice with irradiated Trypanosoma cruzi grown in cell culture: relations of numbers of parasites, immunizing injections and route of immunization to resistance. Int. J. Parasitol. 6:341.
41. Marsden, P. D. 1967. Trypanosoma cruzi infections in CFI mice. I. Mortality with different doses of trypanosomes. Ann. Trop. Med. Parasitol. 61:57.
42. Brener, Z., and E. Chiari. 1963. Variacões morfologicas observadas em diferentes amostras de Trypanosoma cruzi. Rev. Inst. Med. Trop. Sao Paulo 5:220.
43. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
44. Dragon, E., S. Sias, E. Kato, and J. Gabe. 1987. The genome of Trypanosoma cruzi contains a constitutively expressed, tandemly arranged multicopy gene homologous to a major heat shock protein. Mol. Cell. Biol. 7:1271.
45. Pereira, M., J. Mejia, E. Ortega-Barria, D. Matzilevich, and R. Prioli. 1991. The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin. J. Exp. Med. 174:179.
46. Kahn, S., T. Colbert, J. Wallace, N. Hoagland, and H. Eisen. 1991. The major 85-kDa surface antigen of the mammalian-stage forms of Trypanosoma cruzi is a family of sialidases. Proc. Natl. Acad. Sci. USA 88:4481.
47. Takle, G., and G. Cross. 1991. An 85-kilodalton surface antigen gene family of Trypanosoma cruzi encodes polypeptides homologous to bacterial neuraminidases. Mol. Biochem. Parasitol. 48:185.
48. Franco, F., G. Paranhos-Bacalla, L. Yamauchi, N. Yoshida, and S. J. da Silveira. 1993. Characterization of a cDNA clone encoding the carboxy-terminal domain of a 90-kilodalton surface antigen of Trypanosoma cruzi metacyclic trypomastigotes. Infect. Immun. 61:4196.
49. Van Voorhis, W., L. Schlekewy, and H. Trong. 1991. Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc. Natl. Acad. Sci. USA 88:5993.
50. Kahn, S., W. Van Voorhis, and H. Eisen. 1990. The major 85-kD surface antigen of the mammalian form of Trypanosoma cruzi is encoded by a large heterogeneous family of simultaneously expressed genes. J. Exp. Med. 172:589.
51. Pollevick, G., J. Affranchino, A. Frasch, and D. Sanchez. 1991. The complete sequence of a shed acute-phase antigen of Trypanosoma cruzi. Mol. Biochem. Parasitol. 47:247.
52. Campetella, O., A. Uttaro, A. Parodi, and A. Frasch. 1994. A recombinant Trypanosoma cruzi trans-sialidase lacking the amino acid repeats retains the enzymatic activity. Mol. Biochem. Parasitol. 64:337.
53. Uemura, H., S. Schenkman, V. Nussenzweig, and D. Eichinger. 1992. Only some members of a gene family in Trypanosoma cruzi encode proteins that express both trans-sialidase and neuraminidase activities. EMBO J. 11:3837.
54. Fouts, D., B. Ruef, P. Ridley, R. Wrightsman, D. Peterson, and J. Manning. 1991. Nucleotide sequence and transcription of a trypomastigote surface antigen gene of Trypanosoma cruzi. Mol. Biochem. Parasitol. 46:189.
55. Ruef, B., B. Dawson, D. Tewari, D. Fouts, and J. Manning. 1994. Expression and evolution of members of the Trypanosoma cruzi trypomastigote surface antigen multigene family. Mol. Biochem. Parasitol. 63:109.
56. Teixeira, S., D. Russell, L. Kirchhoff, and J. Donelson. 1994. A differentially expressed gene family encoding "amastin," a surface protein of Trypanosoma cruzi amastigotes. J. Biol. Chem. 269:20509.
57. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. Rammensee. 1991. Exact prediction of a natural T cell epitope. Ear. J. Immunol. 21:2891.
58. Kast, W., and C. Melief. 1991. Fine peptide specificity of cytotoxic T lymphocytes directed against adenovirus-induced tumors and peptide-MHC binding. Int. J. Cancer Suppl. 6:90.
59. Ljunggren, H., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162: 1745.
60. Attaya, M., S. Jameson, C. Martinez, E. Hermel, C. Aldrich, J. Forman, K. Lindahl, M. Bevan, and J. Monaco. 1992. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355:647.
61. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
62. Alexander, J., J. Payne, R. Murray, J. Frelinger, and P. Cresswell. 1989. Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics 29:380.
63. Hu-Li, J., J. Ohara, C. Watson, W. Tsang, and W. Paul. 1989. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800.
64. Hammerling, G., E. Rusch, N. Tada, S. Kimura, and U. Hammerling. 1982. Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc. Natl. Acad. Sci. USA 79:4737.
65. Townsend, A., C. Ohlen, J. Bastin, H. Ljunggren, L. Foster, and K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443.
66. Ljunggren, H., N. Stam, C. Ohlen, J. Neefjes, P. Hoglund, M. Heemels, J. Bastin, T. Schumacher, A. Townsend, K. Karre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
67. b-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22:2663.
68. Sarmiento, M., A. Glasebrook, and F. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
69. Ceredig, R., J. Lowenthal, M. Nabholz, and H. MacDonald. 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells.
70. Nabors, G., and R. Tarleton. 1991. Differential control of IFN-γ and IL-2 production during Trypanosoma cruzi infection. J. Immunol. 146:3591.
71. Schumacher, J., A. O'Garra, B. Shrader, K. A. van, M. Bond, T. Mosmann, and R. Coffman. 1988. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J. Immunol. 141:1576.
72. Peterson, D., R. Wrightsman, and J. Manning. 1986. Cloning of a major surface-antigen gene of Trypanosoma cruzi and identification of a nonapeptide repeat. Nature 322:566.
73. + T cells can be primed in vitro to produce IL-4. J. Immunol. 148:1652.
74. Croft, M., L. Carter, S. Swain, and R. Dutton. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715.
75. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271.
76. Silva, L. H. P., and V. Nussenzweig. 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o comundongo branco. Folia Clin. Biol. 20:191.
77. Kast, W., R. Offringa, P. Peters, A. Voordouw, R. Meloen, d. E. A. van, and C. Melief. 1989. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59:603.
78. Burgess, D., and W. Hanson. 1979. Adoptive transfer of protection against Trypanosoma cruzi with lymphocytes and macrophages. Infect. Immun. 25:838.
79. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85:573.
80. + T cells in resistance to cutaneous leishmaniasis in immunized mice. J. Immunol. 142:2052.
81. + T cell immunity against fatal Toxoplasma gondii infection in mice. J. Immunol. 147:3501.
82. Tarleton, R. 1988. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells. J. Immunol. 140:2763.
83. Schenkman, S., D. Eichinger, M. Pereira, and V. Nussenzweig. 1994. Structural and functional properties of Trypanosoma trans-sialidase. Annu. Rev. Microbiol. 48:499.
84. Rosenberg, I., R. Prioli, E. Ortega-Barria, and M. Pereira. 1991. Stage-specific phospholipase C-mediated release of Trypanosoma cruzi neuraminidase. Mol. Biochem. Parasitol. 46:303.
85. Romero, P., J. Maryanski, G. Corradin, R. Nussenzweig, V. Nussenzweig, and F. Zavala. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323.
86. + cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infect. Immun. 62:2979.
87. Salgame, P., J. Abrams, C. Clayberger, H. Goldstein, J. Convit, R. Modlin, and B. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279.
88. Dutton, R. 1996. The regulation of the development of CD8 effector T cells. J. Immunol. 157:4287.
89. + Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J. Immunol. 157:4811.
90. Reed, S. 1988. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol. 140:4342.
91. Silva, J., P. Morrissey, K. Grabstein, K. Mohler, D. Anderson, and S. Reed. 1992. Interleukin 10 and IFN-γ regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169.
92. Black, C., D. Israelski, Y. Suzuki, and J. Remington. 1989. Effect of recombinant tumor necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi. Immunology 68:570.
93. + T cell clones correlates with their levels of expression of adhesion molecules. J. Exp. Med. 175:895.
94. Kulkarni, A., P. Collins, I. Bacik, J. Yewdell, J. Bennink, J. J. Crowe, and B. Murphy. 1995. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 69:1261.
95. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 175: 1531.
96. Ando, K., L. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R. Schreiber, H. Schlicht, S. Huang, and F. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245.
97. Guidotti, L., T. Ishikawa, M. Hobbs, B. Matzke, R. Schreiber, and F. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25.
98. Munoz-Fernandez, M., M. Fernandez, and M. Fresno. 1992. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22:301.
99. Williams, G., T. Brown, L. Becker, M. Prager, and B. Giroir. 1994. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am. J. Physiol. 267:R1020.
100. Balligand, J., D. Ungureanu-Longrois, W. Simmons, D. Pimental, T. Malinski, M. Kapturczak, Z. Taha, C. Lowenstein, A. Davidoff, and R. Kelly. 1994. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J. Biol. Chem. 269:27580.
101. Zhang, L., and R. Tarleton. 1996. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exp. Parasitol. 84:203.
102. Higuchi, M., T. De Brito, M. Reis, A. Barbosa, G. Bellotti, A. Pereira-Barreto, and F. Pileggi. 1993. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc. Pathol. 2:101.
103. Brandariz, S., A. Schijman, C. Vigliano, P. Arteman, R. Viotti, C. Beldjord, and M. Levin. 1995. Detection of parasite DNA in Chagas' heart disease. Lancet 346:1370.
104. Bellotti, G., E. Bocchi, A. V. de Moraes, M. L. Higuchi, M. Barbero-Marcial, E. Sosa, A. Esteves-Filho, R. Kalil, R. Weiss, A. Jatene, and F. Pileggi. 1996. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am. Heart J. 131:301.